Frozen Shoulder and Diabetes

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Frozen shoulder — adhesive capsulitis — is fibrosis and contracture of the glenohumeral joint capsule, and is roughly 5 times more common in people with diabetes than in the general population.
  • Diabetic frozen shoulder tends to last longer, recur more often, and involve both shoulders more frequently than in non-diabetic adults — 10 to 20 percent of people with diabetes are affected during their lifetime.
  • The classic stages are freezing (painful loss of motion, 6 weeks to 9 months), frozen (less pain, severely restricted motion, 4 to 12 months), and thawing (gradual return of motion, 6 months to 2 years).
  • Diagnosis is clinical — pain and global loss of active and passive shoulder motion, especially external rotation, with plain X-rays mainly used to rule out arthritis or rotator cuff calcification.
  • Treatment combines physical therapy, NSAIDs, intra-articular corticosteroid injections (with awareness of short-term glucose rise), hydrodilatation, and capsular release surgery in refractory cases.

Frozen shoulder, or adhesive capsulitis, is a painful loss of shoulder motion caused by fibrosis and contracture of the glenohumeral joint capsule. It is about 5 times more common in people with diabetes, often involves both shoulders, and lasts longer than in non-diabetic adults. The typical course passes through freezing, frozen, and thawing stages over 1 to 3 years. Treatment combines physical therapy, NSAIDs, intra-articular steroid injection, hydrodilatation, and capsular release surgery in refractory cases.

What Frozen Shoulder Is

The glenohumeral joint is enclosed in a fibrous capsule that allows the wide range of motion typical of the shoulder. In adhesive capsulitis the capsule thickens, becomes inflamed, and forms adhesions with neighboring tissues. The result is mechanical restriction in all planes of motion — particularly external rotation and abduction. Because the restriction is in the capsule itself, both active and passive motion are limited; the patient cannot move the arm fully even when the examiner lifts it.

The condition can be primary (idiopathic) or secondary to trauma, surgery, immobilization, or systemic disease. Diabetes is the most important systemic risk factor; thyroid disease, Parkinson disease, and prior stroke also raise risk. The general population lifetime risk is 2 to 5 percent; in diabetes it climbs to 10 to 20 percent.

Why It Happens More in Diabetes

  • Advanced glycation end-products (AGEs) cross-link collagen in the capsule
  • Microvascular changes alter capsular blood supply
  • Increased fibroblast and myofibroblast activity
  • Up-regulation of TGF-beta and other pro-fibrotic cytokines
  • Reduced shoulder use because of foot complications or general deconditioning
  • Coexistent musculoskeletal problems (Dupuytren contracture, trigger finger, carpal tunnel)

Risk Factors

Factor Notes
Type 1 or type 2 diabetes Both raise risk
Long diabetes duration More than 10 years confers highest risk
Higher A1C Correlates with risk and severity
Age 40 to 60 Most common decade for primary frozen shoulder
Female sex Female predominance overall
Thyroid disease Independent risk factor
Prior shoulder injury or surgery Secondary adhesive capsulitis
Other musculoskeletal complications Often coexist in diabetes

Stages

Stage Typical Duration Features
Freezing 6 weeks to 9 months Increasing pain, gradual motion loss
Frozen 4 to 12 months Pain decreases, motion severely restricted
Thawing 6 months to 2 years Gradual return of motion

Symptoms

  • Deep shoulder pain, often worse at night and with movement
  • Progressive stiffness — difficulty reaching behind back, dressing, combing hair
  • Loss of external rotation is the hallmark
  • Pain may radiate to the upper arm
  • Often bilateral in diabetes — may affect the second shoulder a year or two later
  • Functional impact on dressing, hygiene, work, and sleep

Diagnosis

Clinical Examination

  • Active and passive range of motion testing — both restricted
  • External rotation usually the most limited
  • Pain at end range
  • Tenderness to palpation often diffuse
  • Rule out rotator cuff weakness, instability, and impingement

Imaging

  • Plain X-rays — usually normal; rule out arthritis, calcific tendinitis, fracture
  • MRI not routinely required; may show capsular thickening (more than 4 mm) and rotator interval inflammation
  • Ultrasound to rule out rotator cuff tear if clinical suspicion

Laboratory

  • A1C and thyroid function tests because of associated conditions
  • Inflammatory markers usually normal

Treatment

Physical Therapy

  • Pendulum exercises, passive stretching, capsular stretches
  • Frequent, gentle, daily home program
  • Avoid aggressive forced stretching, which can worsen inflammation
  • Therapy continues through all three stages
  • Heat or moist heat before stretching may help

Medications

  • NSAIDs for pain (consider GI and renal cautions)
  • Acetaminophen as adjunct
  • Short course oral steroids occasionally used — weighed against glucose rise
  • Neuropathic pain agents (gabapentin, duloxetine) rarely needed

Intra-Articular Corticosteroid Injection

  • Triamcinolone 20 to 40 mg or methylprednisolone 40 mg in lidocaine
  • Ultrasound or fluoroscopic guidance preferred for accuracy
  • Most beneficial in the freezing stage
  • Glucose may rise 50 to 100 mg/dL for several days — adjust diabetes meds proactively
  • Limit to 2 to 3 injections per shoulder per year

Hydrodilatation

  • Ultrasound-guided injection of saline, anesthetic, and steroid to expand the capsule
  • Often combined with physical therapy
  • Modest improvement in motion in some studies

Manipulation Under Anesthesia

  • Forceful passive motion under general anesthesia
  • Higher complication rates in diabetes (capsular tearing, fracture)
  • Less popular than arthroscopic release

Arthroscopic Capsular Release

  • Surgical division of contracted capsule, especially rotator interval and inferior capsule
  • Reserved for refractory cases after 6 to 12 months of conservative care
  • Postoperative physical therapy critical to maintain motion gains
  • Good outcomes in most patients; full recovery still takes months

Glycemic Control During Steroid Use

Strategy Notes
Pre-injection counseling Warn about glucose rise for several days
Home glucose monitoring Increase frequency for a week
Temporary insulin adjustment Often 10 to 20 percent dose increase
Add or increase basal insulin if on orals Short-term
Confirm no active infection Steroids could worsen
Avoid in poorly controlled diabetes Optimize first if feasible

Prognosis

  • Most non-diabetic frozen shoulders resolve in 1 to 2 years
  • Diabetic cases often take 2 to 4 years, with residual mild stiffness in many
  • Bilateral involvement is common
  • Recurrence in the same shoulder is uncommon after resolution
  • Surgery offers good results for refractory cases

Prevention

  • Maintain shoulder range of motion with regular activity
  • Address shoulder pain early before motion is lost
  • Glycemic control — see our A1C levels guide
  • Mobilize promptly after any upper limb injury or surgery
  • Address coexisting musculoskeletal problems such as Dupuytren contracture
  • Treat thyroid disease appropriately
  • See our complications and related conditions hub for related musculoskeletal complications

The Bottom Line

Frozen shoulder is five times more common in diabetes and tends to be more severe, bilateral, and persistent. Diagnosis is clinical — painful global restriction of active and passive shoulder motion, especially external rotation. Treatment combines physical therapy, NSAIDs, intra-articular steroid injection (with attention to short-term glucose rise), hydrodilatation, and arthroscopic capsular release for refractory cases. Most diabetic frozen shoulders resolve over 2 to 4 years, sometimes with residual stiffness. Talk to your doctor about a structured stretching program at the first sign of shoulder stiffness, and seek prompt evaluation for shoulder pain that limits dressing or sleep.

Frequently Asked Questions

Why is frozen shoulder more common in diabetes?

The link is well established but not fully understood. Hypotheses include glycation of collagen in the capsule, microvascular changes, low-grade inflammation, and increased fibroblast activity. Both type 1 and type 2 diabetes raise risk, and long disease duration and higher A1C correlate with risk. Many people with diabetic frozen shoulder also have other musculoskeletal problems such as Dupuytren contracture and trigger finger.

How long does diabetic frozen shoulder last?

Total duration is typically 1 to 3 years, sometimes longer. Diabetic frozen shoulder tends to be more severe and slower to resolve than non-diabetic cases. Many people regain functional but not full motion. Active rehabilitation usually shortens the course compared with watchful waiting alone.

Will a steroid injection raise blood sugar?

Yes — intra-articular triamcinolone or methylprednisolone is absorbed systemically and typically raises blood glucose for 2 to 7 days, sometimes longer. The rise can be substantial (50 to 100 mg/dL or more). It is usually safe in people with reasonable diabetes control, with temporary insulin or oral agent adjustment if needed. People with very poor control or recurrent DKA may want to defer or use lower-dose injections.

When is surgery needed for frozen shoulder?

Surgery — usually arthroscopic capsular release — is considered when 6 to 12 months of physical therapy, NSAIDs, and one or more steroid injections have not restored functional motion. Manipulation under anesthesia is an alternative but is less popular in diabetic patients because of higher rates of capsular tearing and refracture. Outcomes are generally good, though recovery can still take many months.

Sources

  1. American Academy of Orthopaedic Surgeons. Adhesive capsulitis clinical practice guidelines.
  2. American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Care 47(Suppl 1).